Skip Content
 
Page Banner Image

Enroll-HD Study

Back to map

Funded by CHDI Foundation, Inc.

Enroll-HD is a worldwide observational study for HD families that monitors how HD appears and changes in people over time. The study’s overarching goal is to accelerate the discovery and development of new therapeutics through a better understanding of HD. The study is now generating high-quality clinical and biological data that, once anonymized to protect privacy, is available for use by HD researchers worldwide. The study also serves as a database of volunteers who may be interested in participating in clinical research, including interventional drug trials. Enroll-HD is also looking to improve care for HD patients by identifying the best clinical practice across sites around the world, and will work to distribute the findings to the community.

Enroll-HD is open to people who either have or are at-risk for HD. People who are at-risk but haven’t been tested can take part in Enroll-HD without knowing or being told their genetic status. Further information on all aspects of Enroll-HD can be found at www.Enroll-HD.org.

Status
This study is currently recruiting participants. 

Formal Name
Enroll-HD: A Prospective Registry Study in a Global Huntington’s Disease Cohort

Study Type    
Observational [Patient Registry]

Purpose
Enroll-HD is a longitudinal, observational, multinational study that integrates two other HD registries, REGISTRY in Europe and COHORT in North America and Australia, while also expanding to include sites in Latin America and Asia. With annual assessments and no end date, Enroll-HD is building a comprehensive database of longitudinal clinical information and biospecimens that will be used to develop tools and biomarkers for disease progression and prognosis, identify clinically-relevant disease characteristics, and establish clearly-defined endpoints for interventional studies.

Canadian Locations and Contact Information

British Columbia
Location: University of British Columbia, Vancouver
Status: Recruiting
Coordinator: Allison Coleman
Phone: 604-822-7739

Alberta
Location: University of Calgary, Movement Disorders Program, Calgary
Status: Recruiting
Coordinator: Lorelei Tainsh (nee Derwent)
Phone: 403-220-8413
Or
Coordinator: Carol Pantella
Phone: 403-220-2276

Location: University of Alberta Hospital, Edmonton
Status: Recruiting
Coordinator: Paul McCann
Phone: 780-407-1614

Location: University of Alberta, Edmonton
Status: Recruiting
Coordinator: Pam King
Phone: 780-250-3876

Ontario
Location: Centre for Movement Disorders, Toronto
Status: Recruiting
Coordinator: Teena Kailasanathan
Phone: 416-847-7084 ext 235

Location: North York General Hospital, Toronto
Status: Recruiting
Coordinator: Clare Gibbons
Phone: 416-756-6788

Quebec
Location: CHUM Hospital of Notre Dame, Montreal
Status: Recruiting
Coordinator: Suzanne Paris
Phone: 514-890-8000 ext 26511
Or
Coordinator:   Monica Beland
Phone: 514-890-8000 ext 26512

Nova Scotia
Location: Nova Scotia Health Authority, Halifax
Status: Recruiting
Coordinator: Susannah Piercey
Phone: 902-719-8291

Exclusion Criteria       (individuals who do not meet inclusion criteria)

  • Individuals with choreic movement disorders in the context of a negative test for the HD gene mutation.
  • For Community Controls: those individuals with a major central nervous system disorder will be excluded (e.g. stroke, Parkinson disease, multiple sclerosis, etc.).
  • Participants under 18 may be eligible to participate (if they have juvenile Huntington disease).

Source                        

ClinicalTrials.gov A service of the U.S. National Institutes of Health
Verified April 2015 by CHDI Foundation, Inc.
Information provided by (Responsible Party): CHDI Foundation, Inc.
ClinicalTrials.gov Identifier: NCT01574053

For more detailed information on this study and others and for the most recent updates, please go to clinicaltrials.gov ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.

Back to map


Leave a Reply

You must be logged in to post a comment.


We support those facing huntington disease
 Latest Blog
 Questions

Questions

Let Us Know How We Can Help
Enter your name, email address and question(s) below for assistance.

 Connect
 Newsletter

Newsletter

Stay in Touch!
Enter your email address below to receive occasional updates.

Newsletter Sign-up